Page 3 - Sobi Investor Relations Team News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Swedish Orphan Biovitrum AB: Aspaveli® (pegcetacoplan) approved in Europe for use among treatment naïve adult patients with PNH

Swedish Orphan Biovitrum AB: Aspaveli® (pegcetacoplan) approved in Europe for use among treatment naïve adult patients with PNH
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesZwei rohstoff chancenAspaveli empaveliExperte carsten storkPrnewswire sobiAnn hematolSobi investor relations teamEuropean unionEuropean commissionLydia abad franchMedical affairsChief medical officerNorth americaMiddle eastSobi media

Swedish Orphan Biovitrum AB: Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A

Swedish Orphan Biovitrum AB: Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNordrhein westfalenDennis riedlPrnewswire sobiLydia abad franchHead of researchCommittee for medicinal products human useSobi investor relations teamEuropean commissionEuropean medicines agencyMedicinal productsHuman useMedical affairsChief medical officerAlfa prophylaxisSevere haemophilia

Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus

/PRNewswire/ Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the.

United statesGerard tobinMannheimer swartlingSvenska handelsbankenSobi investor relations teamDanske bankSwedish financial supervisory authority swSwedish financial supervisory authorityNorth americaMiddle eastSobi mediaSwedish orphan biovitrum ab

Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A

/PRNewswire/ Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion.

United statesLydia abad franchPrnewswire sobiCommittee for medicinal products human useSobi investor relations teamEuropean commissionEuropean medicines agencyHead of researchMedicinal productsHuman useMedical affairsChief medical officerAlfa prophylaxisSevere haemophiliaEnglj medOrphan drug

Swedish Orphan Biovitrum AB: Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio

Swedish Orphan Biovitrum AB: Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAspaveli empaveliGerard tobinDennis riedlSobi investor relations teamPerformance measuresNorth americaMiddle eastSobi mediaAktien sie